6533b86dfe1ef96bd12c9b59

RESEARCH PRODUCT

“Weekly docetaxel (DOC) and Gemcitabine (GEM) as first line treatment for metastatic breast cancer (MBC): results of a multicenter phase II study”

Sergio Palmeri

subject

http://hdl.handle.net/10447/6184